Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04738890
Other study ID # EllieCraig2021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2, 2021
Est. completion date February 2, 2022

Study information

Verified date March 2022
Source Canterbury Christ Church University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to conduct an initial evaluation of adapted, live online, mindfulness-based cognitive therapy for parents and carers of children with food allergies (MBCT-PCCFA).


Description:

This study is a pilot randomised controlled trial (RCT) comparing adapted, live online, mindfulness-based cognitive therapy for parents and carers of children with food allergies (MBCT-PCCFA) with a treatment as usual control. A battery of self-report measures will be administered online at baseline (week 0), post-intervention (week 15) and at follow-up (week 23).


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date February 2, 2022
Est. primary completion date December 8, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Parents or caregivers who identify as having a child under the age of 18 with a food allergy - The allergy has been diagnosed by a qualified physician (e.g. GP or allergy specialist) - Mean score of >=2 on the FAQL-PB, indicating they are at least 'somewhat limited/troubled' by their child's allergy (Cohen et al., 2004). - Resident in the United Kingdom - Have access to email, a PC/laptop/tablet with a webcam and microphone and internet access to allow videoconferencing Exclusion Criteria: - They had consulted on the design and content of the intervention or study - They have already participated in a substantial mindfulness-based course - They are currently engaged or are planning to engage with another psychological intervention during the course of the study - They currently engage in regular mindfulness-based practice - They do not have the practical means and time available to be able to attend the intervention during the dates outlined on the information sheet and commit to at-home practice - They have scores >19 on PHQ-8 (indicating 'severe' depressive symptom severity; Kroenke et al., 2009) or >15 on GAD (indicating 'severe' level of anxiety; Spitzer et al., 2006) - They have a problem with alcohol or recreational drug misuse - They have experienced thoughts about harming themselves or others in the last 12 months - They have been given a diagnosis of psychosis - They are currently experiencing high levels of distress and/or currently feeling particularly fragile - They have experienced a bereavement of someone close to them in the last year or are continuing to experience continuing grief in relation to losing someone further back in time - They have had traumatic experiences that they continue to be troubled by (including, but not limited to, receiving diagnosis of post-traumatic stress disorder) - They experience significant difficulty being in a group with other people. NB: for further details re the FAQL-PB and PHQ-8, please see the outcome measures section.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness-based cognitive therapy
Mindfulness-based cognitive therapy adapted for parents and carers of children with food allergy (MBCT-PCCFA) offered live online by video-conferencing
Other:
Treatment as usual
Continuance as planned of whatever other treatments or interventions the participants were receiving at the time of recruitment.

Locations

Country Name City State
United Kingdom Salomons Institute for Applied Psychology Tunbridge Wells Kent

Sponsors (2)

Lead Sponsor Collaborator
Canterbury Christ Church University University of Surrey

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline at week 15 on the Food Allergy Quality of Life-Parental Burden scale - 17 item version (FAQL-PB) This measures quality of life in parents of children with food allergies producing a score between 17 and 119, with higher scores indicating a greater burden on the family. Post intervention (week 15)
Secondary Change from baseline at week 23 on the Food Allergy Quality of Life-Parental Burden scale - 17 item version (FAQL-PB) This measures quality of life in parents of children with food allergies producing a score between 17 and 119, with higher scores indicating a greater burden on the family. Follow up (week 23)
Secondary Change from baseline at week 15 on the Generalized Anxiety Disorder screener - 7 items (GAD-7) This measures symptoms of anxiety producing a score between 0 and 21, with higher scores indicating greater symptom severity. Post intervention (week 15)
Secondary Change from baseline at week 23 on the Generalized Anxiety Disorder screener - 7 items (GAD-7) This measures symptoms of anxiety producing a score between 0 and 21, with higher scores indicating greater symptom severity. Follow up (week 23)
Secondary Change from baseline at week 15 on the Patient Health Questionnaire - 8 items (PHQ-8) This measures symptoms of depression producing a score between 0 and 24, with higher scores indicating greater symptom severity. Post intervention (week 15)
Secondary Change from baseline at week 23 on the Patient Health Questionnaire - 8 items (PHQ-8) This measures symptoms of depression producing a score between 0 and 24, with higher scores indicating greater symptom severity. Follow up (week 23)
Secondary Change from baseline at week 15 on the Perceived Stress Scale - 10 items (PSS) This measures the perception of stress producing a score between 0 and 40, with higher scores indicating greater perceived stress. Post intervention (week 15)
Secondary Change from baseline at week 23 on the Perceived Stress Scale - 10 items (PSS) This measures the perception of stress producing a score between 0 and 40, with higher scores indicating greater perceived stress. Follow up (week 23)
Secondary Change from baseline at week 15 on the Five-Facet Mindfulness Questionnaire - 15 items (FFMQ-15) This measures trait mindfulness producing a score from 15 to 75, with higher score indicating greater trait mindfulness. Post intervention (week 15)
Secondary Change from baseline at week 23 on the Five-Facet Mindfulness Questionnaire - 15 items (FFMQ-15) This measures trait mindfulness producing a score from 15 to 75, with higher score indicating greater trait mindfulness. Follow up (week 23)
Secondary Change from baseline at week 15 on the Perth Emotional Reactivity Scale Short Form - 18 items This measures emotional reactivity producing a score between 30 and 90, with higher scores indicating greater emotional reactivity. Post intervention (week 15)
Secondary Change from baseline at week 23 on the Perth Emotional Reactivity Scale Short Form - 18 items This measures emotional reactivity producing a score between 30 and 90, with higher scores indicating greater emotional reactivity. Post intervention (week 23)
Secondary Change from baseline at week 15 on the Leiden Index of Depression Sensitivity-Revised - 34 items This measures cognitive reactivity producing a score between 0 and 136, with higher scores indicating greater cognitive reactivity. Post intervention (week 15)
Secondary Change from baseline at week 23 on the Leiden Index of Depression Sensitivity-Revised - 34 items This measures cognitive reactivity producing a score between 0 and 136, with higher scores indicating greater cognitive reactivity. Post intervention (week 23)